ITUS Pushes CAR-T Program for Solid Tumors, Develops Early Cancer Detection Platform Post author:Sam Post published:November 28, 2017 Post category:BioPharma Tiny ITUS believes it is on track to develop a CAR-T treatment for solid tumors. Source: BioSpace You Might Also Like Astellas Takes Out Belgium Biotech in Deal Worth $853 Million April 2, 2017 Alnylam Significantly Expands Patent Portfolio With New Allowances From United States Patent And Trademark Office June 11, 2017 Waiting Lists are Already Forming for Novartis AG and Kite Pharma's Not-Yet Approved CAR-T Drugs July 6, 2017
Alnylam Significantly Expands Patent Portfolio With New Allowances From United States Patent And Trademark Office June 11, 2017
Waiting Lists are Already Forming for Novartis AG and Kite Pharma's Not-Yet Approved CAR-T Drugs July 6, 2017
